Search Page

1

Cite

Trends in Selective Childhood Measles-Mumps-Rubella (MMR) Vaccine Nonreceipt Surrounding the MMR-Autism Controversy: National Immunization Survey Analyses, 1996-2019.

Shapiro T, Kuperstein H, MacPherson C. Shapiro T, et al. J Community Health. 2026 Jul 15. doi: 10.1007/s10900-026-01598-3. Online ahead of print. J Community Health. 2026. PMID: 42458106

Cite

2

Cite

Safety and Immunogenicity of Live-Attenuated Measles-Mumps-Rubella Vaccination After Pediatric Heart Transplantation.

Rosenthal LM, Seifert-Hansen M, Scavuzzo L, Marrato A, Dipchand AI. Rosenthal LM, et al. J Heart Lung Transplant. 2026 Jul 15:S1053-2498(26)01994-7. doi: 10.1016/j.healun.2026.07.013. Online ahead of print. J Heart Lung Transplant. 2026. PMID: 42456835

Cite

3

Cite

Measles outbreaks as signals of governance failure: Lessons from Bangladesh's 2026 immunisation collapse.

Jahan Y, Aziz AB. Jahan Y, et al. Vaccine. 2026 Jul 15;88:128924. doi: 10.1016/j.vaccine.2026.128924. Online ahead of print. Vaccine. 2026. PMID: 42456565

Cite

4

Cite

Measles outbreaks in Nepal: sustaining rapid response through equity-focused immunization and surveillance.

G C A, G C B. G C A, et al. Ann Med Surg (Lond). 2026 Jun 5;88(7):4773-4775. doi: 10.1097/MS9.0000000000005189. eCollection 2026 Jul. Ann Med Surg (Lond). 2026. PMID: 42433817 Free PMC article.

Cite

5

Cite

Measles-Containing Vaccine Use for Children Aged 12 to 47 Months, 2015 to 2025.

Fagalde MS, Page LC, Marder EP, Shim MM, Bogan S, Patel D, Kay MK, Chow EJ. Fagalde MS, et al. JAMA Netw Open. 2026 Jul 1;9(7):e2622734. doi: 10.1001/jamanetworkopen.2026.22734. JAMA Netw Open. 2026. PMID: 42430172 Free PMC article.

Cite

6

Cite

Surveillance and analysis of adverse events following immunization (AEFI) with measles, mumps, and rubella (MMR) vaccine in Zhejiang Province, China, 2020-2025.

Pan X, Chen Y, He H, Qi X, Shen L, Liang H. Pan X, et al. Front Public Health. 2026 Jun 17;14:1846354. doi: 10.3389/fpubh.2026.1846354. eCollection 2026. Front Public Health. 2026. PMID: 42388760 Free PMC article.

Cite

7

Cite

Safe seroconversion after receiving measles, mumps, and rubella live vaccine during guselkumab treatment for psoriasis.

Kim K, Kirshen C. Kim K, et al. JAAD Case Rep. 2026 May 27;73:175-176. doi: 10.1016/j.jdcr.2026.05.006. eCollection 2026 Jul. JAAD Case Rep. 2026. PMID: 42388427 Free PMC article. No abstract available.

Cite

8

Cite

Beyond immunity gaps: health-system constraints and measles mortality in Bangladesh.

Hossain MS. Hossain MS. Trop Med Health. 2026 Jul 1;54(1):121. doi: 10.1186/s41182-026-01018-1. Trop Med Health. 2026. PMID: 42387587 Free PMC article.

Cite

9

Cite

Minor differences in the untranslated regions of measles vector additional transcription units are reflected by differential immunogenicity of encoded MERS-CoV Spike antigen.

Tiwarekar V, Ebenig A, Predota Y, Schrauf S, Hörner C, Lange MV, Gadalla MR, Auste A, Miskey C, Muraleedharan S, Konstantoulas C, Schürmann C, Lupinek D, Fiedler AH, Ramsauer K, Tauber E, Mühlebach MD. Tiwarekar V, et al. J Virol. 2026 Jul 1:e0064426. doi: 10.1128/jvi.00644-26. Online ahead of print. J Virol. 2026. PMID: 42383724

Cite

10

Cite

Measles Outbreak in Bangladesh: An Urgent Call to Reinforce Immunization and Public Health Resilience.

Khan MK. Khan MK. Mymensingh Med J. 2026 Jul;35(3):668-669. Mymensingh Med J. 2026. PMID: 42375031

Cite

11

Cite

Measles vaccination status and evidence of immunity among medical students in Catalonia (Spain), 2023-2025: a cross-sectional study.

Domínguez A, Soldevila N, Toledo D, Casas I, Aldea M, Prat A, Bartolomé R, Borràs E, Godoy P; Working Group on Vaccine Preventable Diseases in Medical Students. Domínguez A, et al. BMC Med Educ. 2026 Jun 26. doi: 10.1186/s12909-026-09779-3. Online ahead of print. BMC Med Educ. 2026. PMID: 42351131 Free article.

Cite

12

Cite

Lessons for Immunisation Policy and Practice From the Deadly Measles Resurgence in Bangladesh.

Haque MM, Rahman J, Hassan S, Talukdar IH, Islam MZ, Rahman KM, Paynter J. Haque MM, et al. Trop Med Int Health. 2026 Jun 25. doi: 10.1111/tmi.70190. Online ahead of print. Trop Med Int Health. 2026. PMID: 42350150

Cite

13

Cite

Spatiotemporal Dynamics of the 2025-2026 Measles Outbreak in Mexico: Jalisco as the Emerging Epicenter and the Impact of Intensive Immunization Efforts.

Sandoval-Pinto E, Cremades R, Pérez-Gómez HR, Rivera-Ávila RC, Barbosa CAD, Premkumar L, Sierra-Díaz E, Martínez-Fernández DE, Regla-Nava JÁ. Sandoval-Pinto E, et al. Pathogens. 2026 May 27;15(6):572. doi: 10.3390/pathogens15060572. Pathogens. 2026. PMID: 42347184 Free PMC article.

Cite

14

Cite

Single-cell profiling of immune activation, dysregulation, and reconstitution in rhesus macaques after measles virus infection.

Chan AKP, Baumgarth N, Griffin DE. Chan AKP, et al. J Immunol. 2026 Jun 7;215(6):vkag139. doi: 10.1093/jimmun/vkag139. J Immunol. 2026. PMID: 42343163 Free article.

Cite

15

Cite

Evolution and Future Directions of the National Measles Immunization Program in the Republic of Korea.

Lee H, Jeong H, Hwang H, Choi M, Lee JY, Lee H. Lee H, et al. Public Health Wkly Rep. 2026 Apr 29;19(23 Suppl):1-16. doi: 10.56786/PHWR.2026.19.23suppl.1. eCollection 2026. Public Health Wkly Rep. 2026. PMID: 42339321 Free PMC article.

Cite

16

Cite

Vaccine coverage and quarantine during a school-based measles outbreak, South Carolina, USA, 2025-2026.

Chen S, Hupert N, Bento AI. Chen S, et al. Vaccine. 2026 Jun 22;88:128860. doi: 10.1016/j.vaccine.2026.128860. Online ahead of print. Vaccine. 2026. PMID: 42330775 No abstract available.

Cite

17

Cite

Immunization continuity failures and measles vaccine dropout in a fragile urban setting: Evidence from Mogadishu, Somalia.

Hussein AS, Osman AN, Ahmed GD, Ibrahim LA, Mohamed SH, Mohamed SJ, Abdullahi AA. Hussein AS, et al. Public Health Pract (Oxf). 2026 Jun 3;12:100819. doi: 10.1016/j.puhip.2026.100819. eCollection 2026 Dec. Public Health Pract (Oxf). 2026. PMID: 42327005 Free PMC article.

Cite

18

Cite

VACCINE HESITANCY AND MEASLES OUTBREAKS.

Kohli HS. Kohli HS. Natl Med J India. 2026 Jul-Aug;39(4):264-265. doi: 10.25259/NMJI_407_2026. Natl Med J India. 2026. PMID: 42325023 Free article. No abstract available.

Cite

19

Cite

Distinct Humoral Response Development to Measles Virus across Vaccine Platforms.

Chan AKP, Brockhurst JK, Liu L, Ghimire S, Baumgarth N, Griffin DE. Chan AKP, et al. J Infect Dis. 2026 Jun 17:jiag309. doi: 10.1093/infdis/jiag309. Online ahead of print. J Infect Dis. 2026. PMID: 42308538 Free article.

Cite

20

Cite

Health system stakeholders' perceptions of religious and socio-cultural influences on measles vaccine hesitancy in Madagascar: a qualitative study.

Alain F, Raharinivo M, Razafimahatratra MJJ, Randrianasolo FH, Ramananjanahary H, Andriambelo MM, Andrianirinarison JC, Tsivahiny P, Sahondranirina HP, Yasmine LL, Ratsiambakaina D. Alain F, et al. BMC Public Health. 2026 Jun 15. doi: 10.1186/s12889-026-28130-5. Online ahead of print. BMC Public Health. 2026. PMID: 42298532 Free article.

Cite

21

Cite

Corrigendum to "Estimating the effect of measles vaccination on child growth using 191 DHS from 65 low- and middle-income countries" [Vaccine 37 (2019) 5073-5088].

Bogler L, Jantos N, Bärnighausen T, Vollmer S. Bogler L, et al. Vaccine. 2026 Jun 12;88:128813. doi: 10.1016/j.vaccine.2026.128813. Online ahead of print. Vaccine. 2026. PMID: 42284806 No abstract available.

Cite

22

Cite

Determinants of measles-rubella second dose vaccine uptake among children in Mathare informal settlement, Nairobi, Kenya: a mixed-methods study.

Kamande K, Matiang'i M, Dawa J. Kamande K, et al. Pan Afr Med J. 2026 Jan 29;53:43. doi: 10.11604/pamj.2026.53.43.49226. eCollection 2026. Pan Afr Med J. 2026. PMID: 42283040 Free PMC article.

Cite

23

Cite

Measles: Why the vaccine still works after 60 years.

Maenaka K, Kita S, Fukuhara H. Maenaka K, et al. Cell Host Microbe. 2026 Jun 10;34(6):983-985. doi: 10.1016/j.chom.2026.05.012. Cell Host Microbe. 2026. PMID: 42269586

Cite

24

Cite

Estimates of vaccine effectiveness against measles and mumps: 14 years follow-up of a large cohort in Wales, UK.

Perry M, Gravenor MB, Cottrell S, Moore C, Griffiths LJ. Perry M, et al. Int J Epidemiol. 2026 Apr 17;55(3):dyag083. doi: 10.1093/ije/dyag083. Int J Epidemiol. 2026. PMID: 42250256 Free PMC article.

Cite

25

Cite

Vitamin A and body weight status do not impact humoral immunity against measles, mumps or rubella in individuals 4 to 18 years old: a cross-sectional cohort study in India.

Ratishvili T, Teodoro LI, Quach HQ, Ovsyannikova IG, Jones SP, Joseph I, Pillai MR, Poland GA, Jacob J, Kennedy RB. Ratishvili T, et al. Vaccine. 2026 Jul 11;87:128775. doi: 10.1016/j.vaccine.2026.128775. Epub 2026 Jun 2. Vaccine. 2026. PMID: 42229095 Free PMC article.

Cite

26

Cite

Health worker practices and challenges surrounding routine immunisation service delivery of measles-containing vaccine: a cross-sectional assessment of health facilities in Oromia region, Ethiopia - 2021.

Gelmessa TD, Woyessa AB, Shah MP, Matanock AM, Nkengasong S, Azmeraye BM, Pan J, Lisanwork L, Yimer G, Wang SH, An Q, Samuel P, Gonfa BT, Kenate B, Hurissa AB, Wako G, Shiferaw A, Tefera YL, Kokebie MA, Anbessie TB, Wubie HT, Wallace AS, Sugerman CE. Gelmessa TD, et al. BMJ Public Health. 2026 May 21;4(2):e004520. doi: 10.1136/bmjph-2025-004520. eCollection 2026. BMJ Public Health. 2026. PMID: 42205618 Free PMC article.

Cite

27

Cite

Duration of vaccine-induced immunity following MMR2 vaccination in a measles and rubella-eliminated country.

Chun JY, Kim AR, Jeong H, Kim YJ, Kang HJ, Jeong HS, Rhie GE, Jee Y, Kim Y, Lee J. Chun JY, et al. Int J Epidemiol. 2026 Apr 17;55(3):dyag076. doi: 10.1093/ije/dyag076. Int J Epidemiol. 2026. PMID: 42201837 Free PMC article.

Cite

28

Cite

Sustaining herd immunity against measles: Insights from a serological cohort study in an outbreak-free population.

Amadi M, Vänskä S, Davidkin I, Haario H, Leino T, Melin M, Auranen K, Kontio M. Amadi M, et al. Infection. 2026 May 27. doi: 10.1007/s15010-026-02832-9. Online ahead of print. Infection. 2026. PMID: 42201515

Cite

29

Cite

Machine Learning-Based Severity Stratification for Smart Preventive Decision Support: Evidence from Measles Surveillance in a Resource-Constrained Region.

Baiașu AF, Dinescu VC, Bică CE, Rotaru-Zăvăleanu AD, Boldea AM, Vasile RC, Șerbănescu MS, Florescu RM. Baiașu AF, et al. J Clin Med. 2026 May 14;15(10):3757. doi: 10.3390/jcm15103757. J Clin Med. 2026. PMID: 42194719 Free PMC article.

Cite

30

Cite

Immunogenicity and safety of an investigational quadrivalent measles, mumps, rubella, and varicella vaccine in children aged 4-6 years: A phase II, randomized, multi-country trial.

Habib MA, Hughes T, Huang LM, Deseda C, Zavadska D, Povey M, Raja R, Demoitié MA, Kondagunta VH; MMRVNS 20-001 study group. Habib MA, et al. Hum Vaccin Immunother. 2026 Dec;22(1):2660525. doi: 10.1080/21645515.2026.2660525. Epub 2026 May 26. Hum Vaccin Immunother. 2026. PMID: 42189573 Free PMC article. Clinical Trial.

Cite

31

Cite

Assessment of Measles Immunity in the Croatian Population: A Retrospective Seroprevalence Study, 2015-2025.

Vilibić-Čavlek T, Barbić K, Vučina VV, Bogdanić M, Kaić B. Vilibić-Čavlek T, et al. Vaccines (Basel). 2026 Apr 27;14(5):393. doi: 10.3390/vaccines14050393. Vaccines (Basel). 2026. PMID: 42188766 Free PMC article.

Cite

32

Cite

A large measles outbreak in Zimbabwe related to vaccine hesitancy in 2022.

Chiwara N, Tshuma E, Mashiringo C, Simbi R, Mukaratirwa A, Shonhai A, Katsande R, Rupfutse M, Byabamazima C, Tiruneh D, Masresha B. Chiwara N, et al. Pan Afr Med J. 2026 Feb 4;53:59. doi: 10.11604/pamj.2026.53.59.48564. eCollection 2026. Pan Afr Med J. 2026. PMID: 42180626 Free PMC article.

Cite

33

Cite

Intramuscular Immunoglobulin for Measles Postexposure Prophylaxis.

[No authors listed] [No authors listed] NEJM Evid. 2026 Jun;5(6):EVIDx2600161. doi: 10.1056/EVIDx2600161. Epub 2026 May 15. NEJM Evid. 2026. PMID: 42139680 No abstract available.

Cite

34

Cite

Measles-Mumps-Rubella-Varicella Vaccine.

[No authors listed] [No authors listed] 2026 May 15. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. 2026 May 15. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. PMID: 30000747 Free Books & Documents. Review.

Cite

35

Cite

Measles-Mumps-Rubella Vaccine.

[No authors listed] [No authors listed] 2026 May 15. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. 2026 May 15. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. PMID: 30000093 Free Books & Documents. Review.

Cite

36

Cite

Intramuscular Immunoglobulin for Measles Postexposure Prophylaxis.

Weil A, Jones A, Mansfield K, Pavia AT, White A, Nolen LD. Weil A, et al. NEJM Evid. 2026 Jun;5(6):EVIDpha2600093. doi: 10.1056/EVIDpha2600093. Epub 2026 May 13. NEJM Evid. 2026. PMID: 42126932

Cite

37

Cite

Interplay between vaccine-related informational milestones, social media discourse, and vaccine administration rates for human papillomavirus and measles/mumps/rubella vaccines in the United States.

Annan A, Wang D, Du J, Nomula VK, Rastegar-Mojarad M, Frew PM, Eiden AL. Annan A, et al. Hum Vaccin Immunother. 2026 Dec;22(1):2655512. doi: 10.1080/21645515.2026.2655512. Epub 2026 May 11. Hum Vaccin Immunother. 2026. PMID: 42113956 Free PMC article.

Cite

38

Cite

Measles resurgence in Bangladesh, 2026: A warning of fragile immunization gains.

Haider N, Hassan MZ, Khan RA. Haider N, et al. Int J Infect Dis. 2026 May 6;170:108765. doi: 10.1016/j.ijid.2026.108765. Online ahead of print. Int J Infect Dis. 2026. PMID: 42102902 Free article. No abstract available.

Cite

39

Cite

Immunization gaps and measles outbreaks in ASEAN (2015-2025): A systematic review and meta-analysis.

Mercado VJ, Contreras DL, Wongnak P, Yamin FY, Chatchen S, Ngamprasertchai T, Pan-Ngum W. Mercado VJ, et al. J Infect Public Health. 2026 Jun;19(6):103238. doi: 10.1016/j.jiph.2026.103238. Epub 2026 Apr 29. J Infect Public Health. 2026. PMID: 42085724 Free article. Review.

Cite

40

Cite

Why do we have a vaccine for measles, but not cytomegalovirus (CMV)?

Schleiss MR, Permar SR, Plotkin SA. Schleiss MR, et al. PLoS Pathog. 2026 May 4;22(5):e1014136. doi: 10.1371/journal.ppat.1014136. eCollection 2026 May. PLoS Pathog. 2026. PMID: 42081591 Free PMC article. No abstract available.

Cite

41

Cite

Harnessing pre-existing measles immunity: mRNA-Lipid nanoparticle-mediated measles hemagglutinin expression boosts antitumor CD8+ T cell responses.

Martínez-Latorre J, Soriano-Teruel PM, Candela-Noguera V, Acúrcio RC, Florindo HF, García-Fernández A, Martínez-Máñez R. Martínez-Latorre J, et al. Signal Transduct Target Ther. 2026 May 4;11(1):164. doi: 10.1038/s41392-026-02716-2. Signal Transduct Target Ther. 2026. PMID: 42071000 Free PMC article. No abstract available.

Cite

42

Cite

Forecasting and optimal control model to assess the potential role of vaccine hesitancy and supportive care in East Java measles outbreak.

Chukwu CW, Herdicho FF, Rois MA, Fatmawati. Chukwu CW, et al. Comput Biol Med. 2026 Jul 1;210:111707. doi: 10.1016/j.compbiomed.2026.111707. Epub 2026 May 2. Comput Biol Med. 2026. PMID: 42070370

Cite

43

Cite

Measles is resurging in Bangladesh-but this outbreak was entirely preventable.

Raqib R, Rahman M. Raqib R, et al. BMJ. 2026 Apr 29;393:s819. doi: 10.1136/bmj.s819. BMJ. 2026. PMID: 42055588 No abstract available.

Cite

44

Cite

Bangladesh launches measles vaccine drive amid outbreak.

Lateef S. Lateef S. Lancet Infect Dis. 2026 Apr 23:S1473-3099(26)00226-4. doi: 10.1016/S1473-3099(26)00226-4. Online ahead of print. Lancet Infect Dis. 2026. PMID: 42035786 No abstract available.

Cite

45

Cite

Unusual measles mortality in Bangladesh signals an immunisation emergency.

Jamil S, Asif U, Mohammadnezhad M. Jamil S, et al. Lancet. 2026 Apr 25;407(10539):1596-1597. doi: 10.1016/S0140-6736(26)00687-2. Epub 2026 Apr 20. Lancet. 2026. PMID: 42026009 No abstract available.

Cite

46

Cite

Waning of measles immunity by 5 years of age following an accelerated two-dose measles vaccine schedule at 6 and 12 months in South African children: an observational cohort study.

Kapelus DJ, Ranchod H, Olwagen CP, Koen A, Mutsaerts EAML, Jose L, Kwatra G, Madhi SA. Kapelus DJ, et al. Vaccine. 2026 May 10;81:128580. doi: 10.1016/j.vaccine.2026.128580. Epub 2026 Apr 11. Vaccine. 2026. PMID: 41967185 Free article.

Cite

47

Cite

Gaps in knowledge, receipt, and acceptance of measles, mumps, rubella vaccines in a National Sample of emergency department patients.

Malireddy S, Eftimie A, Ge S, Alvarez C, Torres J, Chinnock B, Gottlieb M, Kumar VA, Rising KL, Kean ER, Eucker S, Rodriguez RM. Malireddy S, et al. Am J Emerg Med. 2026 Jul;105:73-78. doi: 10.1016/j.ajem.2026.03.022. Epub 2026 Mar 27. Am J Emerg Med. 2026. PMID: 41966547

Cite

48

Cite

Evaluation of Coverage Rates of 3 Pediatric Vaccines (Measles-Mumps-Rubella, Hexavalent, and Varicella) in a Southern Italian Province (2016-2022): Effect of the Pandemic and Interregional Comparisons.

Santoro E, Manente R, Nappa M, Nigro A, D'Anna A, Catapano F, Longanella W, Costantino M, Fornino D, Capunzo M, Boccia G. Santoro E, et al. Med Sci Monit. 2026 Apr 10;32:e951332. doi: 10.12659/MSM.951332. Med Sci Monit. 2026. PMID: 41961762 Free PMC article.

Cite

49

Cite

Seroprevalence of measles immunoglobulin G antibodies in Bahrain: A cross-sectional study using fever and rash surveillance data (2021-2025).

Alsayyad A, Matar E, Zabar Z, Husain M, Hasan W, Hasan M, Hasan M, Radhi J, Safar BA, Mohamed A. Alsayyad A, et al. IJID Reg. 2026 Mar 7;19:100871. doi: 10.1016/j.ijregi.2026.100871. eCollection 2026 Jun. IJID Reg. 2026. PMID: 41953297 Free PMC article.

Cite

50

Cite

Real-world effectiveness of measles vaccine and associated factors among children aged 9-59 months during epidemic resurgence in the Democratic Republic of Congo: a nationwide test-negative case-control study.

Tembele WN, Nkosi Nsona P, Nguend A, Ndanu F, Eale B, Ahuka Mundeke S, Mangyanda LK, Kaba D, Katuashi Ishoso D. Tembele WN, et al. Trop Dis Travel Med Vaccines. 2026 Apr 8;12(1):15. doi: 10.1186/s40794-026-00298-z. Trop Dis Travel Med Vaccines. 2026. PMID: 41952203 Free PMC article.

Cite

51

Cite

Corrigendum to "Clinico-virological investigation of measles complications in immunocompromised pediatric patients" Infection, Genetics and Evolution 139 (2026) 105918.

Vaidya SR, Sharma S, Kamble MB, Sreedeep KS, Deepthi B, Kulkarni S, Gade S, Pandey PG, Joshi M, Divatia J, Dhamne CA. Vaidya SR, et al. Infect Genet Evol. 2026 Jun;140:105937. doi: 10.1016/j.meegid.2026.105937. Epub 2026 Apr 4. Infect Genet Evol. 2026. PMID: 41935878 Free article. No abstract available.

Cite

52

Cite

Deterioration of immunization resilience: A Bayesian machine learning assessment of the 2025-2026 measles outbreak in Mexico.

Colombo-Mendoza LO, Villalobos-Espinosa JDC, Beltrán-Naturi E. Colombo-Mendoza LO, et al. Int J Infect Dis. 2026 Jun;167:108666. doi: 10.1016/j.ijid.2026.108666. Epub 2026 Apr 1. Int J Infect Dis. 2026. PMID: 41933695 Free article.

Cite

53

Cite

Exploring socio-economic inequalities in measles immunisation in Lao People's Democratic Republic, Thailand, and Viet Nam.

Lorenzo JC, Islam MI, Mathieu E. Lorenzo JC, et al. Vaccine. 2026 Apr 30;80:128507. doi: 10.1016/j.vaccine.2026.128507. Epub 2026 Mar 31. Vaccine. 2026. PMID: 41921477 Free article.

Cite

54

Cite

Fractional-order modeling of vaccination strategies for measles transmission incorporating immune memory.

Yunus AO, Olanrewaju OA. Yunus AO, et al. Virus Res. 2026 May;367:199718. doi: 10.1016/j.virusres.2026.199718. Epub 2026 Mar 28. Virus Res. 2026. PMID: 41912117 Free PMC article.

Cite

55

Cite

Decreasing Antibody Titers and the Slow Decay of Measles Immunity in Mexico's Current Epidemiological Landscape.

Muñoz-Valle JF, Macedo-Ojeda G, Turrubiates-Hernández FJ, Hernández-Bello J, García-Arellano S, Hernández-Ramírez CO, Baños-Hernández CJ, Coronado-Carrillo PM, Lona-Reyes JC, Viera-Segura O. Muñoz-Valle JF, et al. Vaccines (Basel). 2026 Mar 4;14(3):234. doi: 10.3390/vaccines14030234. Vaccines (Basel). 2026. PMID: 41893771 Free PMC article.

Cite

56

Cite

Sex-based differences in mumps immunity after a third dose of measles-mumps-rubella vaccine.

Quach HQ, Ratishvili T, Haralambieva IH, Ovsyannikova IG, Poland GA, Kennedy RB. Quach HQ, et al. Vaccine. 2026 Apr 19;79:128480. doi: 10.1016/j.vaccine.2026.128480. Epub 2026 Mar 20. Vaccine. 2026. PMID: 41863912 Free PMC article.

Cite

57

Cite

Real-World Evaluation of Allergic Reactions to Two Measles, Mumps, and Rubella Vaccine Formulations in Children with Egg and/or Cow's Milk Allergy.

Tekcan D, Celik IK, Artac H. Tekcan D, et al. Int Arch Allergy Immunol. 2026 Mar 21:1-7. doi: 10.1159/000551656. Online ahead of print. Int Arch Allergy Immunol. 2026. PMID: 41863819

Cite

58

Cite

Coverage, effectiveness, and sero-positivity of measles-containing vaccines in low- and lower middle-income countries: An umbrella review of systematic reviews and meta-analyses.

Mohammed Y, Olowo-Okere A, Bawa S, Onah JO, Saad A, Oteri A, Yusufari YA, Wonodi C, Umar ZA, Kolawole AF, Hassan S, Garba AR. Mohammed Y, et al. Int J Infect Dis. 2026 Jun;167:108569. doi: 10.1016/j.ijid.2026.108569. Epub 2026 Mar 19. Int J Infect Dis. 2026. PMID: 41862080 Free article.

Cite

59

Cite

Early Measles Vaccination in Infants Less than 12 Months: Global Practices, Immunity Outcomes, and Implications for Disease Prevention.

AlSaihati A, Chaudhary M, Olarte L. AlSaihati A, et al. J Pediatric Infect Dis Soc. 2026 Feb 4;15(4):piag018. doi: 10.1093/jpids/piag018. J Pediatric Infect Dis Soc. 2026. PMID: 41818477 Review.

Cite

60

Cite

Measles Outbreak - New Mexico, 2025.

Stanislawski E, Romero A, Holzinger N, Healy R, Webb NJ, Cruz K, Sievers M, Aung S, Swisher S, Stefanos R, Yara-Zelenski J, Kofman AD, Pierce R, Onyeuku C, Pilote KM, Leung J, Smelser C. Stanislawski E, et al. MMWR Morb Mortal Wkly Rep. 2026 Mar 12;75(9):111-115. doi: 10.15585/mmwr.mm7509a1. MMWR Morb Mortal Wkly Rep. 2026. PMID: 41818136 Free article.

Cite

61

Cite

Evaluation of vaccine immunity against tetanus, hepatitis B, measles, mumps, rubella and varicella, in migrant adolescents aged 13 to 18 years arriving in Geneva in 2023.

Mühlstein-Barasche J, Gualtieri R, Wagner N, Chamay-Weber C, Posfay-Barbe K, Blanchard-Rohner G. Mühlstein-Barasche J, et al. Eur J Pediatr. 2026 Mar 12;185(4):177. doi: 10.1007/s00431-026-06843-4. Eur J Pediatr. 2026. PMID: 41817808

Cite

62

Cite

Measles Resurgence: Could a Third Vaccine Dose Be the Solution?

Chau HTB, Minh BC, Aziz JMA, Van HBT, Tien BNH, Gad A, Nguyen KD, Gam PH, Hamraa J, Hang LTT, Ngan TTK, Son PT, Huy NT. Chau HTB, et al. Rev Med Virol. 2026 Mar;36(2):e70134. doi: 10.1002/rmv.70134. Rev Med Virol. 2026. PMID: 41814671 Review.

Cite

63

Cite

Strengthening measles immunity in Thailand: Rationale for a third vaccine dose to avert outbreaks.

Nilyanimit P, Suntronwong N, Puenpa J, Thongmee T, Klinfueng S, Wanlapakorn N, Poovorawan Y. Nilyanimit P, et al. Vaccine. 2026 Apr 19;79:128438. doi: 10.1016/j.vaccine.2026.128438. Epub 2026 Mar 10. Vaccine. 2026. PMID: 41812631

Cite

64

Cite

Clinico-virological investigation of measles complications in immunocompromised pediatric patients.

Vaidya SR, Sharma S, Kamble MB, Sreedeep KS, Deepthi B, Kulkarni S, Gade S, Pandey PG, Joshi M, Divatia J, Dhamne CA. Vaidya SR, et al. Infect Genet Evol. 2026 Apr;139:105918. doi: 10.1016/j.meegid.2026.105918. Epub 2026 Mar 5. Infect Genet Evol. 2026. PMID: 41794164 Free article.

Cite

65

Cite

[National guideline on contact tracing and preventive measures for measles].

Nejat S, Bengnér M. Nejat S, et al. Lakartidningen. 2026 Mar 6;123:25137. Lakartidningen. 2026. PMID: 41789464 Free article. Swedish.

Cite

66

Cite

Cross-sectional seroprevalence study of measles antibodies among children to identify gaps in population immunity, Ireland, 2024.

Brady M, Brouwer L, O' Brien K, Carton M, Whitton L, Dillon C, Finucane J, Culkin F, Perry E, Brabazon E, Gee S, Browne K, Burke D, De Gascun C, Leonard A, Cunney R, O' Connor L. Brady M, et al. Euro Surveill. 2026 Mar;31(9):2500313. doi: 10.2807/1560-7917.ES.2026.31.9.2500313. Euro Surveill. 2026. PMID: 41788028 Free PMC article.

Cite

67

Cite

[Measles immunity in the Swedish population].

Hagstam P, Englund H. Hagstam P, et al. Lakartidningen. 2026 Mar 6;123:25144. Lakartidningen. 2026. PMID: 41787919 Free article. Review. Swedish.

Cite

68

Cite

Measles: An Updated Literature Review of the Host Response, Pathogenesis, Complications, Prevention Measures, and Recent Outbreaks.

Au S, Saini S, Cruz WD, Venketaraman V. Au S, et al. Curr Issues Mol Biol. 2026 Feb 13;48(2):206. doi: 10.3390/cimb48020206. Curr Issues Mol Biol. 2026. PMID: 41751468 Free PMC article. Review.

Cite

69

Cite

Immunity gap for measles in young adults: Seroprevalence study in blood donors in southern Italy.

Centrone F, Melilli R, Colella V, Latela A, Marziani A, Lattarulo S, Ostuni A, Sallustio A, Chironna M. Centrone F, et al. Hum Vaccin Immunother. 2026 Dec;22(1):2634496. doi: 10.1080/21645515.2026.2634496. Epub 2026 Feb 24. Hum Vaccin Immunother. 2026. PMID: 41734895 Free PMC article.

Cite

70

Cite

Routine immunization intensification, vaccination campaigns, and measles transmission in Southern Nigeria.

Thakkar N, Oteri AJ, McCarthy KA. Thakkar N, et al. PLoS One. 2026 Feb 18;21(2):e0341016. doi: 10.1371/journal.pone.0341016. eCollection 2026. PLoS One. 2026. PMID: 41706747 Free PMC article.

Cite

71

Cite

Immunization registries: an essential tool for measles elimination in Canada.

Brown EM, Chambers C, Wilson SE. Brown EM, et al. CMAJ. 2026 Feb 16;198(6):E224-E225. doi: 10.1503/cmaj.251433. CMAJ. 2026. PMID: 41702627 Free PMC article. No abstract available.

Cite

72

Cite

Centered on Child Health: Zhu Futang and the Foundations of Pediatrics and Measles Prevention in China.

Liu H, Zhang L, Xiang Q, Cheng H. Liu H, et al. Protein Cell. 2026 Feb 16:pwag008. doi: 10.1093/procel/pwag008. Online ahead of print. Protein Cell. 2026. PMID: 41698838 Free article. No abstract available.

Cite

73

Cite

Assessing measles immunity in individuals of childbearing age in Toronto, Ontario, Canada.

Osman S, Science M, McLachlan E, Severini A, Arnold C, Petel D, Hatchette T, Deeks S, Halperin SA, Wright J, Brown K, Richardson S, Campigotto A, Crowcroft N, Bolotin S. Osman S, et al. J Infect. 2026 Mar;92(3):106701. doi: 10.1016/j.jinf.2026.106701. Epub 2026 Feb 13. J Infect. 2026. PMID: 41692289 Free article.

Cite

74

Cite

Uptake of measles second dose vaccine among children aged 15-35 months at Mettu Woreda, Illu Aba Bor Zone, Ethiopia: A community-based cross-sectional study.

Haile AW, Kebede EB, Bagilkar V, Mamo TW, Gembe M. Haile AW, et al. PLoS One. 2026 Feb 12;21(2):e0342931. doi: 10.1371/journal.pone.0342931. eCollection 2026. PLoS One. 2026. PMID: 41678530 Free PMC article.

Cite

75

Cite

Problem-Based Learning Case of Unvaccinated Child With Measles Infection: Integrating Viral Pathogenesis, Immunology, and Vaccine Ethics.

Onello EC, Skildum A, Fitzakerley JL, Clarke BL. Onello EC, et al. MedEdPORTAL. 2026 Feb 6;22:11577. doi: 10.15766/mep_2374-8265.11577. eCollection 2026. MedEdPORTAL. 2026. PMID: 41676317 Free PMC article.

Cite

76

Cite

Evaluation of measles immunity in the central black sea region of Turkiye.

Kalayci HO, Ibik YE, Calgin MK. Kalayci HO, et al. BMC Infect Dis. 2026 Feb 9;26(1):546. doi: 10.1186/s12879-026-12779-9. BMC Infect Dis. 2026. PMID: 41663988 Free PMC article.

Cite

77

Cite

Two vaccine-associated measles cases: Transmission or coincidental cases?

Hernandez-Aceituno A, Sanabria Curbelo D, Falcón García I, Torres Lana Á, Montesdeoca Melián RA, Larumbe-Zabala E. Hernandez-Aceituno A, et al. Enferm Infecc Microbiol Clin (Engl Ed). 2026 Feb;44(2):503071. doi: 10.1016/j.eimce.2026.503071. Enferm Infecc Microbiol Clin (Engl Ed). 2026. PMID: 41654379

Cite

78

Cite

Persistent measles immunization gaps in LMICs: Insights from the 2024 revision of the WHO/UNICEF estimates of National Immunization Coverage.

Mwale M. Mwale M. Vaccine. 2026 Mar 7;75:128298. doi: 10.1016/j.vaccine.2026.128298. Epub 2026 Jan 31. Vaccine. 2026. PMID: 41621116

Cite

79

Cite

Resurgence of measles in the United States: Examining the outbreak, vaccine hesitancy, and future directions.

Edward M. Edward M. Glob Public Health. 2026 Dec 31;21(1):2624148. doi: 10.1080/17441692.2026.2624148. Epub 2026 Jan 30. Glob Public Health. 2026. PMID: 41618620 Free article.

Cite

80

Cite

The measles vaccine's effectiveness during an epidemic: a test negative case control study (Tunisia, 2019).

Bennasrallah C, Maatouk A, Kacem M, Dhouib W, Mhamdi M, Said SG, Amiche C, Dabghi R, Zemni I, Gara A, Bouanène I, Sriha AB, Abroug H, Fredj MB. Bennasrallah C, et al. BMC Infect Dis. 2026 Jan 28;26(1):414. doi: 10.1186/s12879-025-12460-7. BMC Infect Dis. 2026. PMID: 41606528 Free PMC article.

Cite

81

Cite

US measles outbreak gives "real world" data on the unvaccinated, CDC vaccine chair says, as he questions polio jab.

Tanne JH. Tanne JH. BMJ. 2026 Jan 27;392:s175. doi: 10.1136/bmj.s175. BMJ. 2026. PMID: 41592815 No abstract available.

Cite

82

Cite

Risk of Measles Vaccine Associated Febrile Seizures among Children 6-59 Months Old in a Federally Qualified Health System, 2008-2024.

Kurlandsky K, Breslin K, Stein A, Brtnikova M, Cruz H, Williams JTB. Kurlandsky K, et al. J Pediatr. 2026 May;292:115009. doi: 10.1016/j.jpeds.2026.115009. Epub 2026 Jan 23. J Pediatr. 2026. PMID: 41581697

Cite

83

Cite

Hybrid microneedle patch for administration of measles and rubella vaccine with an on-patient medical record.

Sadeqi A, Lee JW, Gomaa Y, Nguyen TC, Azizoglu E, Hasin T, Ryu YJ, Dixon JB, Kanelli M, Han J, Langer R, Jaklenec A, Prausnitz MR. Sadeqi A, et al. J Control Release. 2026 Mar 10;391:114635. doi: 10.1016/j.jconrel.2026.114635. Epub 2026 Jan 14. J Control Release. 2026. PMID: 41544667 Free article.

Cite

84

Cite

Repurposing the SSRI paroxetine increases lymphocyte mobilization and improves the efficacy of measles virus-based immunovirotherapy.

Stergiopoulos GM, Concilio SC, Viker KB, Clark SM, Robinson SI, Galanis E. Stergiopoulos GM, et al. Mol Ther Oncol. 2025 Dec 9;34(1):201109. doi: 10.1016/j.omton.2025.201109. eCollection 2026 Mar 19. Mol Ther Oncol. 2025. PMID: 41542034 Free PMC article.

Cite

85

Cite

Prevention and post-exposure prophylaxis for measles in children with inflammatory bowel disease.

Lyles JL, Carson RA. Lyles JL, et al. J Pediatr Gastroenterol Nutr. 2026 Mar;82(3):638-641. doi: 10.1002/jpn3.70336. Epub 2026 Jan 1. J Pediatr Gastroenterol Nutr. 2026. PMID: 41479128 No abstract available.

Cite

86

Cite

A Phase 1 Double-Blinded Trial to Evaluate Safety, Immunogenicity, and Dosing of Measles-Vectored Chikungunya Virus Vaccine (MV-CHIK) in Healthy Adults.

Winokur P, Hegmann TE, El Sahly HM, Anderson EJ; DMID 15-0038 Study Group. Winokur P, et al. J Infect Dis. 2026 Mar 17;233(3):e641-e645. doi: 10.1093/infdis/jiaf571. J Infect Dis. 2026. PMID: 41313671 Free PMC article. Clinical Trial.

Cite

87

Cite

Infection prevention processes implemented at a children's hospital during a community measles outbreak, 2025.

Kovar L, Gould C, Marchand S, Vandygriff C, Hrabowski-Grier D, Hurst L. Kovar L, et al. Am J Infect Control. 2026 Feb;54(2):107-118. doi: 10.1016/j.ajic.2025.10.020. Epub 2025 Oct 29. Am J Infect Control. 2026. PMID: 41167477

Cite

88

Cite

Intralesional measles, mumps, and rubella vaccine versus vitamin D for treatment of warts: A randomised clinical trial.

Sallam M, Awad A, Hamdy S, State A. Sallam M, et al. Indian J Dermatol Venereol Leprol. 2026 Mar-Apr;92(2):285-291. doi: 10.25259/IJDVL_1669_2024. Indian J Dermatol Venereol Leprol. 2026. PMID: 40357930 Free article. Clinical Trial.

Cite